G. S. Morris

1.6k total citations
61 papers, 1.2k citations indexed

About

G. S. Morris is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, G. S. Morris has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Pediatrics, Perinatology and Child Health and 12 papers in Physiology. Recurrent topics in G. S. Morris's work include Biochemical and Molecular Research (17 papers), Neonatal Health and Biochemistry (10 papers) and Cytomegalovirus and herpesvirus research (8 papers). G. S. Morris is often cited by papers focused on Biochemical and Molecular Research (17 papers), Neonatal Health and Biochemistry (10 papers) and Cytomegalovirus and herpesvirus research (8 papers). G. S. Morris collaborates with scholars based in United States, United Kingdom and Canada. G. S. Morris's co-authors include H. Anne Simmonds, Lynette D. Fairbanks, Nancy D. Perrier, Arnold G. Nelson, Jeffrey E. Lee, Maren Hegsted, Elizabeth Grubbs, Dianne Webster, Eric H. Harley and Michael J. Keenan and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Journal of Applied Physiology.

In The Last Decade

G. S. Morris

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. S. Morris United States 20 454 252 241 174 157 61 1.2k
Maurilo Leite Brazil 18 473 1.0× 86 0.3× 143 0.6× 79 0.5× 225 1.4× 47 1.2k
Mohammad Azam Mansoor Norway 24 420 0.9× 98 0.4× 422 1.8× 89 0.5× 64 0.4× 55 2.2k
Daniel Kraus Germany 17 423 0.9× 265 1.1× 191 0.8× 47 0.3× 36 0.2× 54 1.4k
Maria João Martins Portugal 21 355 0.8× 203 0.8× 180 0.7× 91 0.5× 45 0.3× 65 1.3k
K. Try Norway 21 348 0.8× 297 1.2× 99 0.4× 75 0.4× 52 0.3× 43 1.4k
Sayaka Maeda Japan 21 297 0.7× 231 0.9× 189 0.8× 34 0.2× 135 0.9× 52 1.4k
P Garcia‐Webb Australia 21 317 0.7× 114 0.5× 190 0.8× 129 0.7× 117 0.7× 68 1.5k
C.B. Hollenbeck United States 25 668 1.5× 347 1.4× 382 1.6× 169 1.0× 25 0.2× 51 2.2k
Javier Donate‐Correa Spain 26 561 1.2× 163 0.6× 324 1.3× 52 0.3× 975 6.2× 69 2.3k
Rildo Aparecido Volpini Brazil 26 454 1.0× 124 0.5× 272 1.1× 30 0.2× 463 2.9× 60 1.6k

Countries citing papers authored by G. S. Morris

Since Specialization
Citations

This map shows the geographic impact of G. S. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. S. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. S. Morris more than expected).

Fields of papers citing papers by G. S. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. S. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. S. Morris. The network helps show where G. S. Morris may publish in the future.

Co-authorship network of co-authors of G. S. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of G. S. Morris. A scholar is included among the top collaborators of G. S. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. S. Morris. G. S. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, G. S., et al.. (2019). Clinical Pharmacokinetics of a Lipid-Based Formulation of Risperidone, VAL401: Analysis of a Single Dose in an Open-Label Trial of Late-Stage Cancer Patients. European Journal of Drug Metabolism and Pharmacokinetics. 44(4). 557–565. 4 indexed citations
2.
Morris, G. S., et al.. (2017). Pimping up Drugs Recovered, Superannuated and Under Exploited Drugs - An Introduction to the Basics of Drug Reprofiling. Current Drug Discovery Technologies. 14(2). 121–126. 4 indexed citations
3.
Morris, G. S., et al.. (2012). Greater Than Age-Predicted Functional Deficits In Older Patients with Primary Hyperparathyroidism. Endocrine Practice. 18(4). 450–455. 12 indexed citations
4.
Perrier, Nancy D., Christine S. Landry, David Kwon, et al.. (2011). Operative Technique for Single Incision Robot-Assisted Transaxillary Thyroid Surgery. 3(2). 83–88. 3 indexed citations
5.
Landry, Christine S., Elizabeth Grubbs, G. S. Morris, et al.. (2010). Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery. 149(4). 549–555. 94 indexed citations
6.
7.
Perrier, Nancy D., Diwakar D. Balachandran, Jeffrey S. Wefel, et al.. (2009). Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism. Surgery. 146(6). 1116–1122. 70 indexed citations
8.
9.
Hegsted, Maren, et al.. (1997). DOSAGE EFFECTS OF CHROMIUM PICOLINATE ON GROWTH AND BODY COMPOSITION IN THE RAT. Nutrition Research. 17(7). 1175–1186. 19 indexed citations
10.
Nelson, Arnold G., et al.. (1996). Effects of caffeine ingestion on endurance racing in heat and humidity. European Journal of Applied Physiology. 73(3-4). 358–363. 64 indexed citations
11.
Morris, G. S., et al.. (1996). Moderate diabetes alters myosin isoenzyme distribution in cardiac but not skeletal muscle of male rats. Life Sciences. 58(10). 833–838. 9 indexed citations
12.
Morris, G. S., et al.. (1995). Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacity. Life Sciences. 57(24). 2237–2244. 13 indexed citations
13.
Morris, G. S., et al.. (1994). Effects of long-term cocaine administration and exercise on cardiac metabolism and isomyosin expression. Canadian Journal of Physiology and Pharmacology. 72(1). 1–5. 9 indexed citations
14.
Morris, G. S., Daniel P. Fitzsimons, K. M. Baldwin, & R. J. Barnard. (1993). Exercise capacity of rats remains unaffected by a chronic pressure overload. Cardiovascular Research. 27(7). 1346–1349. 12 indexed citations
15.
Morris, G. S., Dariusz Surdyka, F. Haddad, & K. M. Baldwin. (1990). Apparent influence of metabolism on cardiac isomyosin profile of food-restricted rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 258(2). R346–R351. 16 indexed citations
16.
Fairbanks, Lynette D., et al.. (1989). Deoxy GTP Accumulates in Thymocytes, but not in T or B Lymphocytes in Simulated PNP Deficiency. Advances in experimental medicine and biology. 253B. 275–280. 3 indexed citations
17.
Simmonds, H. Anne, Lynette D. Fairbanks, G. S. Morris, Dianne Webster, & Eric H. Harley. (1988). Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism. Clinica Chimica Acta. 171(2-3). 197–210. 83 indexed citations
18.
Morris, G. S., et al.. (1987). Differential effects of carbohydrate intake on cardiac myosin isoform expression in normal weanling and adult rats. Molecular and Cellular Biochemistry. 78(2). 121–9. 2 indexed citations
19.
Simmonds, H. Anne, J. S. Cameron, G. S. Morris, L. D. Fairbanks, & P. M. Davies. (1987). Purine Metabolites in Uraemia. Advances in experimental medicine and biology. 223. 73–80. 8 indexed citations
20.
Morris, G. S., H. Anne Simmonds, & P. M. Davies. (1986). Use of biological fluids for the rapid diagnosis of potentially lethal inherited disorders of human purine and pyrimidine metabolism. Biomedical Chromatography. 1(3). 109–118. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurilo Leite Breakdown of academic impact, for papers by Mohammad Azam Mansoor Breakdown of academic impact, for papers by Daniel Kraus Breakdown of academic impact, for papers by Maria João Martins Breakdown of academic impact, for papers by K. Try Breakdown of academic impact, for papers by Sayaka Maeda Breakdown of academic impact, for papers by P Garcia‐Webb Breakdown of academic impact, for papers by C.B. Hollenbeck Breakdown of academic impact, for papers by Javier Donate‐Correa Breakdown of academic impact, for papers by Rildo Aparecido Volpini
Rankless by CCL
2026